A 12-week, Multicentric Study to Evaluate the Safety and Efficacy of Bisoprolol in Filipino Hypertensive Subjects With Diabetes

Mise à jour : Il y a 4 ans
Référence : NCT01190436

Femme et Homme

  • | Pays :
  • Philippines
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The aim of this 12-week, multicenter, interventional, prospective, open-label and single-arm study is to evaluate the safety and efficacy of 5 milligram per day (mg/day) and 10 mg/day bisoprolol in Filipino hypertensive subjects with diabetes as monotherapy or as an add-on therapy.


Critère d'inclusion

  • Hypertension

Liens